Tapewire

Nasdaq · USD

LNAI

Lunai Bioworks Inc.

Export transactions ↓
Tapewire entity
7981
SEC CIK
0001527728
Parsed reports
159

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2025 Filed Mar 12, 2025 08:12 UTC OtherCommon Stock 350,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001214659-25-004233 · marketforms-68711.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,353,878

F1 · kind: Shares were transferred to RS Group ApS pursuant to a settlement agreement terminating the action entitled RS Group ApS v. GWRS Holdings LLC et al. (Superior Court of Los Angeles County, CA, Case No. 22STCV26335).

F1 · price: Shares were transferred to RS Group ApS pursuant to a settlement agreement terminating the action entitled RS Group ApS v. GWRS Holdings LLC et al. (Superior Court of Los Angeles County, CA, Case No. 22STCV26335).

F2 · balance_after: Includes 88,121 shares held by the Reporting Person and his spouse as joint tenants with a right of survivorship (JTWROS).

Read SEC document
January 21, 2025 Filed Feb 25, 2025 13:33 UTC GrantOption to purchase shares of common stock · Derivative 1,000,000 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001731122-25-000295 · ownership.xml · derivative · entry 2

van Tilburg Maurice · CIK 0002043498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common stock · 1,000,000 shares

Expires 2035-01-21

F2 · derivative.exercise_date: This option vests in five equal annual installments beginning on December 30, 2025.

Read SEC document
January 21, 2025 Filed Feb 25, 2025 13:33 UTC GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001731122-25-000295 · ownership.xml · nonDerivative · entry 1

van Tilburg Maurice · CIK 0002043498 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

F1 · shares: These restricted shares vest in five equal annual installments beginning on December 30, 2025.

Read SEC document
January 21, 2025 Filed Feb 25, 2025 18:29 UTC
Fuentes NathenChief Financial Officer
GrantOption to purchase shares of common stock · Derivative 250,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001731122-25-000293 · ownership.xml · derivative · entry 1

Fuentes Nathen · CIK 0002005072 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common stock · 250,000 shares

Expires 2035-01-21

F1 · derivative.exercise_date: This option vests in eight equal quarterly installments beginning on January 6, 2025.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 16:34 UTC
Tarsh SimonInterim CFO
GrantOption to purchase shares of common stock · Derivative 58,500 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0001731122-24-001725 · ownership.xml · derivative · entry 1

Tarsh Simon · CIK 0001943931 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,500

Underlying: Common stock · 58,500 shares

Expires 2034-11-04

F1 · derivative.exercise_date: This option vests upon the termination of the Consulting Agreement effective November 4, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date.

Read SEC document
November 04, 2024 Filed Nov 6, 2024 20:25 UTC GrantOption to purchase shares of common stock · Derivative 120,968 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0001731122-24-001719 · ownership.xml · derivative · entry 1

MCNULTY JAMES A · CIK 0001275857 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,968

Underlying: Common stock · 120,968 shares

Expires 2034-11-04

Read SEC document
November 04, 2024 Filed Nov 6, 2024 21:54 UTC GrantOption to purchase shares of common stock · Derivative 120,968 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0001731122-24-001729 · ownership.xml · derivative · entry 1

Calder Douglas W · CIK 0001510445 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,968

Underlying: Common stock · 120,968 shares

Expires 2034-11-04

Read SEC document
November 04, 2024 Filed Nov 7, 2024 12:18 UTC GrantOption to purchase shares of common stock · Derivative 120,968 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0001731122-24-001740 · ownership.xml · derivative · entry 1

Collins Mark Anthony · CIK 0002043093 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,968

Underlying: Common stock · 120,968 shares

Expires 2034-11-04

Read SEC document
October 14, 2024 Filed Oct 29, 2024 14:36 UTC
Weinstein David HershelDirector · Chief Executive Officer
GrantOption to purchase shares of common stock · Derivative 1,600,000 $0.00 Strike: $0.55 $0.00
Disclosure

SEC source: 0001731122-24-001669 · ownership.xml · derivative · entry 2

Weinstein David Hershel · CIK 0002042640 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600,000

Underlying: Common stock · 1,600,000 shares

Expires 2034-10-14

F1 · derivative.exercise_date: The option vests in eight equal quarterly installments beginning on January 1, 2025.

Read SEC document
October 14, 2024 Filed Oct 29, 2024 14:36 UTC
Weinstein David HershelDirector · Chief Executive Officer
GrantCommon Stock 250,000 $0.00 $0.00
Disclosure

SEC source: 0001731122-24-001669 · ownership.xml · nonDerivative · entry 1

Weinstein David Hershel · CIK 0002042640 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Read SEC document
August 23, 2024 Filed Aug 27, 2024 16:05 UTC
Miller AvramDirector
GrantOption to Purchase Shares of Common Stock · Derivative 978,261 $0.00 Strike: $0.69 $0.00
Disclosure

SEC source: 0001731122-24-001325 · ownership.xml · derivative · entry 2

Miller Avram · CIK 0002000641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 978,261

Underlying: Common Stock · 978,261 shares

Expires 2034-08-23

F1 · kind: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.

F2 · derivative.exercise_date: The option becomes exercisable in four equal installments on each three-month anniversary of the date of grant.

Read SEC document
August 23, 2024 Filed Aug 27, 2024 16:05 UTC
Miller AvramDirector
Disposition to issuerCommon Stock 833,333 $0.00 $0.00
Disclosure

SEC source: 0001731122-24-001325 · ownership.xml · nonDerivative · entry 1

Miller Avram · CIK 0002000641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,667

F1 · kind: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.

F1 · price: The reporting person agreed to forfeit 833,333 shares of unvested restricted stock previously granted to him by the Issuer on October 23, 2023 in exchange for a new option to purchase 978,261 shares of common stock.

Read SEC document
August 12, 2024 Filed Aug 13, 2024 16:01 UTC
Brink KarenDirector · 10% owner
OtherCommon Stock 2,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-068233 · ownership.xml · nonDerivative · entry 1

Brink Karen · CIK 0002012444 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Yalla Yalla Ltd.

Disclosed balance after: 23,372,969

F1 · kind: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · shares: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · price: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F2 · ownership.nature: The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Read SEC document
August 12, 2024 Filed Aug 16, 2024 16:43 UTC Amendment
Brink KarenDirector · 10% owner
OtherCommon Stock 2,000,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-070297 · ownership.xml · nonDerivative · entry 1

Brink Karen · CIK 0002012444 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Yalla Yalla Ltd.

Disclosed balance after: 25,372,969

F1 · kind: This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · shares: This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · price: This Form 4/A is filed to amend the original Form 4 filed by the reporting person on August 13, 2024, which incorrectly reported the transfer of the common shares. The common shares reported on this Form 4/A were not transferred by Yalla Yalla Ltd. ("Yalla Yalla") to an entity pursuant to a consulting agreement dated August 5, 2024, as payment for certain services rendered to Yalla Yalla.

F2 · ownership.nature: The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Read SEC document
July 29, 2024 Filed Oct 24, 2024 08:56 UTC SaleCommon Stock 1,114 $1.30 $1,448.20
Disclosure

SEC source: 0001214659-24-017879 · marketforms-67178.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 840,319

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.30 to $1.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 17:44 UTC SaleCommon Stock 16,362 $1.46 $23,888.52
Disclosure

SEC source: 0001214659-24-012745 · marketforms-66622.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 841,433

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.45 to $1.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 15, 2024 Filed Jul 17, 2024 16:32 UTC SaleCommon Stock 21,954 $1.41 $30,955.14
Disclosure

SEC source: 0001214659-24-012571 · marketforms-66579.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 875,795

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.40 to $1.44, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 11, 2024 Filed Jul 15, 2024 08:46 UTC SaleCommon Stock 14,896 $1.51 $22,492.96
Disclosure

SEC source: 0001214659-24-012367 · marketforms-66563.xml · nonDerivative · entry 3

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 897,749

F4 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 10, 2024 Filed Jul 15, 2024 08:46 UTC SaleCommon Stock 75,000 $1.51 $113,250.00
Disclosure

SEC source: 0001214659-24-012367 · marketforms-66563.xml · nonDerivative · entry 2

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 894,645

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 09, 2024 Filed Jul 15, 2024 08:46 UTC SaleCommon Stock 4,630 $1.53 $7,083.90
Disclosure

SEC source: 0001214659-24-012367 · marketforms-66563.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 969,645

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.52 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is sole manager of Weird Science LLC.

Read SEC document
July 05, 2024 Filed Jul 8, 2024 16:50 UTC SaleCommon Stock 60,000 $1.55 $93,000.00
Disclosure

SEC source: 0001214659-24-012082 · marketforms-66527.xml · nonDerivative · entry 2

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 974,275

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
July 03, 2024 Filed Jul 8, 2024 16:50 UTC SaleCommon Stock 50,000 $1.51 $75,500.00
Disclosure

SEC source: 0001214659-24-012082 · marketforms-66527.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,034,275

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
July 02, 2024 Filed Jul 3, 2024 19:04 UTC SaleCommon Stock 34,553 $1.54 $53,211.62
Disclosure

SEC source: 0001214659-24-011987 · marketforms-66503.xml · nonDerivative · entry 2

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,084,275

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.50 to $1.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
July 01, 2024 Filed Jul 3, 2024 19:04 UTC SaleCommon Stock 60,000 $1.56 $93,600.00
Disclosure

SEC source: 0001214659-24-011987 · marketforms-66503.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,118,828

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.61, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
June 27, 2024 Filed Jun 27, 2024 19:37 UTC SaleCommon Stock 14,671 $1.50 $22,006.50
Disclosure

SEC source: 0001214659-24-011566 · marketforms-66440.xml · nonDerivative · entry 3

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,178,828

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
June 26, 2024 Filed Jun 27, 2024 19:37 UTC SaleCommon Stock 50,000 $1.57 $78,500.00
Disclosure

SEC source: 0001214659-24-011566 · marketforms-66440.xml · nonDerivative · entry 2

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,193,499

F3 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 18:56 UTC GrantOption to purchase shares of common stock · Derivative 18,634 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001039 · ownership.xml · derivative · entry 1

Hendriks Ruud · CIK 0001996999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,634

Underlying: Common stock · 18,634 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jun 27, 2024 19:37 UTC SaleCommon Stock 20,000 $1.58 $31,600.00
Disclosure

SEC source: 0001214659-24-011566 · marketforms-66440.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,243,499

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
June 25, 2024 Filed Jun 27, 2024 22:54 UTC GrantOption to purchase shares of common stock · Derivative 42,857 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001035 · ownership.xml · derivative · entry 1

Brosgart Carol L · CIK 0001614724 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,857

Underlying: Common stock · 42,857 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jun 27, 2024 22:53 UTC GrantOption to purchase shares of common stock · Derivative 48,137 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001031 · ownership.xml · derivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,137

Underlying: Common stock · 48,137 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jun 27, 2024 22:55 UTC GrantOption to purchase shares of common stock · Derivative 48,137 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001037 · ownership.xml · derivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,137

Underlying: Common stock · 48,137 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jun 27, 2024 22:49 UTC
Sindlev ReneDirector · 10% owner
GrantOption to purchase shares of common stock · Derivative 62,112 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001029 · ownership.xml · derivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 62.112

Underlying: Common stock · 62,112 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jun 27, 2024 22:53 UTC GrantOption to purchase shares of common stock · Derivative 46,584 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001033 · ownership.xml · derivative · entry 1

McNicol Jayne · CIK 0001866827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,584

Underlying: Common stock · 46,584 shares

Expires 2034-06-25

Read SEC document
June 25, 2024 Filed Jul 1, 2024 08:40 UTC
Miller AvramDirector
GrantOption to purchase shares of common stock · Derivative 18,634 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001731122-24-001048 · ownership.xml · derivative · entry 1

Miller Avram · CIK 0002000641 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,634

Underlying: Common stock · 18,634 shares

Expires 2034-06-25

Read SEC document
June 14, 2024 Filed Jun 18, 2024 18:38 UTC SaleCommon Stock 50,000 $1.58 $79,000.00
Disclosure

SEC source: 0001214659-24-011150 · marketforms-66393.xml · nonDerivative · entry 1

William Anderson Wittekind · CIK 0001753085 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Weird Science LLC

Disclosed balance after: 1,263,499

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold at prices ranging from $1.55 to $1.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported range.

F2 · ownership.nature: The Reporting Person is a manager of Weird Science LLC.

Read SEC document
June 06, 2024 Filed Jul 3, 2024 16:05 UTC
Brink KarenDirector · 10% owner
OtherCommon Stock 1,853,517 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-24-059029 · ownership.xml · nonDerivative · entry 1

Brink Karen · CIK 0002012444 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Yalla Yalla Ltd.

Disclosed balance after: 25,372,969

F1 · kind: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · shares: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla.

F1 · price: The common shares reported on this Form 4 were transferred by Yalla Yalla Ltd. ("Yalla Yalla") to two entities pursuant to those certain share transfer agreements dated June 6, 2024, as payment for certain services rendered to Yalla Yalla.

F2 · ownership.nature: The Reporting Person, as ultimate beneficial owner of Yalla Yalla, beneficially owns the securities reported in Column 5 indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Read SEC document
May 26, 2024 Filed May 31, 2024 01:35 UTC GrantOption to Purchase Common Stock · Derivative 52,817 $0.00 Strike: $1.42 $0.00
Disclosure

SEC source: 0001731122-24-000898 · ownership.xml · derivative · entry 1

McNicol Jayne · CIK 0001866827 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,817

Underlying: Common Stock · 52,817 shares

Expires 2034-05-26

Read SEC document
March 11, 2024 Filed Mar 13, 2024 15:50 UTC
Tarsh SimonInterim CFO
GrantOption to purchase shares of common stock · Derivative 10,000 $0.00 Strike: $2.98 $0.00
Disclosure

SEC source: 0001731122-24-000425 · ownership.xml · derivative · entry 1

Tarsh Simon · CIK 0001943931 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-03-11

F1 · derivative.exercise_date: This option vests upon the termination of the Consulting Agreement effective March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date.

Read SEC document
March 06, 2024 Filed Mar 19, 2024 15:18 UTC GrantOption to Purchase Common Stock · Derivative 28,196 $0.00 Strike: $2.66 $0.00
Disclosure

SEC source: 0001731122-24-000455 · ownership.xml · derivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,196

Underlying: Common Stock · 28,196 shares

Expires 2034-03-06

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:35 UTC
Sindlev ReneDirector · 10% owner
OtherWarrant (Right to Buy) · Derivative 471,699 $0.00 Strike: $0.53 $0.00
Disclosure

SEC source: 0001731122-24-000292 · ownership.xml · derivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 471,698

Underlying: Common Stock · 471,699 shares

Expires 2028-06-26

Read SEC document
February 20, 2024 Filed Feb 22, 2024 21:35 UTC
Sindlev ReneDirector · 10% owner
OtherCommon Stock 471,699 $0.53 $250,000.47
Disclosure

SEC source: 0001731122-24-000292 · ownership.xml · nonDerivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 13,605,297

Read SEC document
February 13, 2024 Filed Feb 15, 2024 23:38 UTC
Sindlev ReneDirector · 10% owner
ConversionSeries A Convertible Preferred Stock · Derivative 70,126 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001731122-24-000254 · ownership.xml · derivative · entry 2

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 0

Underlying: Common Stock · 701,260 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The Preferred Stock is convertible into Common Stock on a one-for-ten basis.

F3 · derivative.expiration_date: The Preferred Stock is perpetual and has no expiration date.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 23:38 UTC
Sindlev ReneDirector · 10% owner
ConversionCommon Stock 701,260 Not disclosed Not disclosed
Disclosure

SEC source: 0001731122-24-000254 · ownership.xml · nonDerivative · entry 1

Sindlev Rene · CIK 0001709513 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By RS Bio ApS

Disclosed balance after: 13,133,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Shares of Series A Convertible Preferred Stock ("Preferred Stock") automatically converted into shares of Common Stock on a one-for-ten basis pursuant to their terms. The automatic conversion was triggered by the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. The shares of Preferred Stock were initially acquired by the Reporting Person for $7.13 per share.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
GrantOption to Purchase Common Stock · Derivative 40,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 6

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-10-18

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F3 · derivative.exercise_date: One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
Disposition to issuerOption to Purchase Common Stock · Derivative 40,000 Not disclosed Strike: $2.15 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 5

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2032-10-18

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F3 · derivative.exercise_date: One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
GrantOption to Purchase Common Stock · Derivative 65,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 4

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2032-02-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
Disposition to issuerOption to Purchase Common Stock · Derivative 65,000 Not disclosed Strike: $8.40 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 3

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 65,000 shares

Expires 2032-02-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
GrantOption to Purchase Common Stock · Derivative 65,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 2

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2032-07-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:44 UTC
Binette FrancoisCOO and Executive VP for R&D
Disposition to issuerOption to Purchase Common Stock · Derivative 65,000 Not disclosed Strike: $2.38 Not disclosed
Disclosure

SEC source: 0001731122-24-000268 · ownership.xml · derivative · entry 1

Binette Francois · CIK 0001940686 · COO and Executive VP for R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 65,000 shares

Expires 2032-07-22

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F1 · derivative.exercise_date: 60% of the option vested on January 22, 2023 and 40% on July 22, 2023.

Read SEC document
February 13, 2024 Filed Feb 16, 2024 14:13 UTC
Puche LuisaChief Financial Officer
GrantOption to Purchase Common Stock · Derivative 80,000 Not disclosed Strike: $1.92 Not disclosed
Disclosure

SEC source: 0001731122-24-000264 · ownership.xml · derivative · entry 8

Puche Luisa · CIK 0001768468 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-10-18

F2 · price: The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.

F5 · derivative.exercise_date: One third of the option vested on October 18, 2023, the remainder of the option vests equally on October 18, 2024 and October 18, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.